Kaplan-Meier survival analysis of RGS2 using the online tool GEPIA (http://gepia.cancer-pku.cn/index.html) showed that higher levels of RGS2 were correlated with increased overall survival and disease-free survival in breast cancer patients (Figure 7G) 17. Here, RGS2 is linked to breast carcinoma.